Neonatal Sustained Furosemide Exposure Alters KCC2/NKCC1 Expression and Causes Behavioral Abnormalities during Immature Brain Development

Yue Xu, Nagoya-University Graduate School of Medicine, Nagoya, Aichi, Japan; Atsuto Onoda, Sanyo-Onoda City University, Sanyo-Onoda, Yamaguchi, Japan; Takahiro Kanzawa, Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Aichi, Japan; Ryoko Shimode, Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Gifu, Gifu, Japan; Yukina Takamoto, Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Aichi, Japan; Shintaro Ichimura, Nagoya University hospital, Nagoya, Aichi, Japan; Norika Mamiya, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan; Shota Fujito, nagoya university hospital, nagoya, Aichi, Japan; Sakiko Suzuki, Nagoya University, Nagoya, Aichi, Japan; Zhiyue Deng, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan; Kazuto Ueda, Nagoya University, Nagoya, Aichi, Japan; Ryosuke Miura, Nagoya University Hospital, Nagoya, Aichi, Japan; Toshihiko Suzuki, Nagoya University Hospital,, Nagoya, Aichi, Japan; Yukako Muramatsu, Nagoya university hospital, Nagoya, Aichi, Japan; Yoshiyuki Takahashi, Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan; Yoshiaki Sato, Nagoya University Hospital, Nagoya, Aichi, Japan